June 12, 2024
Osteogenesis Stimulators Added to Required Prior Authorization
On May 13, 2024, CMS announced updates to the Master List and the Required Face-to-Face Encounter and Required Written Order Prior to Delivery (WOPD) List.
CMS selected osteogenesis stimulator HCPCS codes E0747, E0748, E0760 that will require prior authorization. There will be two phases of implementation:
- Phase one begins August 12, 2024, in California, Florida, Ohio, and Pennsylvania.
- Phase two begins November 12, 2024, in all remaining states and territories not included in phase 1.
Learn more about these requirements in MLN Matters Article SE20007.
We will publish more information and education soon.